- April 12, 2021
- Posted by: medium
- Category: International
The bloc is optimistic about the arrival of vaccines from Janssen, a subsidiary of the American Johnson & Johnson, to accelerate vaccination.
This Monday, the pharmaceutical company Janssen began deliveries to all European Union countries of its coronavirus vaccine, of which 55 million doses are expected to arrive between April and June to boost the immunization campaign in the Member States, it confirmed. the European Commission.
“Good news today with the beginning of deliveries of the single-dose Johnson & Johnson vaccine throughout the European Union. “This will help accelerate access to vaccines for citizens and ensure that we reach our goal of vaccinating 70% of the adult population by the summer,” European Health Commissioner Stella Kyriakides wrote on Twitter.
The European Commission is optimistic about the arrival of the Janssen vaccines, a subsidiary of the American multinational Johnson & Johnson,which join those already used in the first quarter (Pfizer, Moderna and AstraZeneca) to accelerate vaccinations in member states, many of which have recorded record vaccine administration data in the first days of April.
The four companies have committed to providing about 360 million doses between April and June, a calculation that already takes into account that AstraZeneca has announced that it will not comply with what was agreed in its contract with Brussels and will deliver 70 million doses instead of 180. .
In any case, the fact that 55 of those 360 million vaccines are Johnson & Johnson's single-dose drug and that Moderna and Pfizer have fulfilled their delivery promises encourages the European Union to think that many countries could reach the goal of 70% of the adult population vaccinated during the summer.
According to an internal calculation of the European Union to which Efe has had access,Spain could have the doses to vaccinate more than 27 million people, 57.41% of the population, by the end of June,counting on all pharmaceutical companies to comply with the drug deliveries stipulated in their contracts with Brussels.
The estimate is more optimistic than the one presented last week by the President of the Government, Pedro Sánchez, who estimated that Spain will have 25 million people immunized by July 19 in an appearance after the meeting of the Council of Ministers.
Some countries, such as Malta (93.1% by the end of June) or Denmark (79.88%), exceed the average pace of the European partners, while only four would remain below half of the vaccinated population by the end for the month of June: Czech Republic (44.67%), Slovakia (45.58%), Bulgaria (45.21%) and Croatia (45.28%).